Carson Wealth (CWM LLC)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$469K Buy
15,579
+8,117
+109% +$261K ﹤0.01% 2065
2025
Q4
$233K Buy
7,462
+2,101
+39% +$51.8K ﹤0.01% 2449
2025
Q3
$108K Buy
5,361
+366
+7% +$6.43K ﹤0.01% 2926
2025
Q2
$84K Buy
4,995
+767
+18% +$12.4K ﹤0.01% 2871
2025
Q1
$65K Buy
4,228
+148
+4% +$2.64K ﹤0.01% 2756
2024
Q4
$90K Sell
4,080
-112
-3% -$2.04K ﹤0.01% 2357
2024
Q3
$76K Buy
4,192
+126
+3% +$2.21K ﹤0.01% 2373
2024
Q2
$66K Buy
4,066
+395
+11% +$6.08K ﹤0.01% 2274
2024
Q1
$52K Buy
3,671
+420
+13% +$5.29K ﹤0.01% 2278
2023
Q4
$34K Buy
3,251
+362
+13% +$3.38K ﹤0.01% 2423
2023
Q3
$29K Buy
2,889
+896
+45% +$8.34K ﹤0.01% 2434
2023
Q2
$15K Sell
1,993
-95
-5% -$770 ﹤0.01% 2840
2023
Q1
$18K Sell
2,088
-102
-5% -$1.01K ﹤0.01% 2589
2022
Q4
$20K Buy
2,190
+163
+8% +$1.42K ﹤0.01% 2385
2022
Q3
$16K Buy
2,027
+204
+11% +$1.8K ﹤0.01% 2396
2022
Q2
$14K Buy
1,823
+200
+12% +$1.74K ﹤0.01% 2387
2022
Q1
$15K Sell
1,623
-147
-8% -$1.23K ﹤0.01% 2265
2021
Q4
$14K Buy
+1,770
New +$16K ﹤0.01% 2183
2021
Q2
$11K Hold
1,105
– – ﹤0.01% 2075
2021
Q1
$11K Hold
1,105
– – ﹤0.01% 2074
2020
Q4
$11K Hold
1,105
– – ﹤0.01% 2073
2020
Q3
$11K Hold
1,105
– – ﹤0.01% 2072
2020
Q2
$11K Hold
1,105
– – ﹤0.01% 2071
2020
Q1
$11K Hold
1,105
– – ﹤0.01% 2071
2019
Q4
$11K Hold
1,105
– – ﹤0.01% 2071
2019
Q3
$11K Hold
1,105
– – ﹤0.01% 2071
2019
Q2
$11K Hold
1,105
– – ﹤0.01% 2071
2019
Q1
$11K Sell
1,105
-6,433
-85% -$113K ﹤0.01% 2071
2018
Q4
$116K Buy
7,538
+1,236
+20% +$25.3K ﹤0.01% 698
2018
Q3
$136K Buy
6,302
+6,300
+315,000% +$146K ﹤0.01% 577
2018
Q2
$0 Sell
2
-63
-97% -$1.28K ﹤0.01% 1776
2018
Q1
$1K Sell
65
-2
-3% -$39 ﹤0.01% 1333
2017
Q4
$1K Sell
67
-300
-82% -$4.51K ﹤0.01% 1399
2017
Q3
$6K Sell
367
-4,244
-92% -$95.5K ﹤0.01% 1041
2017
Q2
$153K Sell
4,611
-1,400
-23% -$43.3K 0.01% 338
2017
Q1
$193K Sell
6,011
-58,050
-91% -$1.98M 0.01% 294
2016
Q4
$2.32M Buy
64,061
+652
+1% +$26K 0.14% 140
2016
Q3
$2.92M Buy
63,409
+24,400
+63% +$1.27M 0.2% 125
2016
Q2
$1.96M Buy
+39,009
New +$2.08M 0.14% 154
2016
Q1
– Sell
-136
Closed -$9K – 812
2015
Q4
$9K Sell
136
-79
-37% -$4.88K ﹤0.01% 480
2015
Q3
$12K Buy
+215
New +$13.9K ﹤0.01% 432

Other funds holding TEVA

Carson Wealth (CWM LLC)'s TEVA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 109% in Q1 2026, buying an estimated $261K and bringing the position to 15,579 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Carson Wealth (CWM LLC) first reported a position in TEVA in Q3 2015 and has held it in 41 quarters since. The position peaked at $2.92M in Q3 2016. 653 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 15,579 shares of Teva Pharmaceutical Industries Limited worth $469K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 8,117 Teva Pharmaceutical Industries Limited shares in Q1 2026, an estimated $261K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2065 holding.
  • Carson Wealth (CWM LLC) first reported a position in Teva Pharmaceutical Industries Limited in Q3 2015 and has held it in 41 quarters since.
  • Carson Wealth (CWM LLC)'s Teva Pharmaceutical Industries Limited position peaked at $2.92M in Q3 2016.
  • 653 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.